Fundz

Rakuten Aspyrian, Inc. reported raising $150 Million in an initial SEC Form D filing, from an offering of $350 Million

PRIVATEAug 23, 2018$150M of $350M raised

Amount Raised

$150 Million

$150 Million sold, per SEC Form D (first sale Aug 23, 2018)

Round Type

Venture

San MateoBiotechnology

Quick answer

Aspyrian Therapeutics, Inc. raised $150 Million in a funding round, dated August 23, 2018. Aspyrian Therapeutics, Inc. is based in San Mateo, California, United States.

How much did Aspyrian Therapeutics, Inc. raise?
Aspyrian Therapeutics, Inc. raised $150 Million in a funding round on August 23, 2018.
What does Aspyrian Therapeutics, Inc. do?
Aspyrian Therapeutics is developing a first-in-class cancer treatment utilizing photoimmunotherapy.
Where is Aspyrian Therapeutics, Inc. based and how big is it?
Aspyrian Therapeutics, Inc. is based in San Mateo, California, United States.
Who are the decision-makers at Aspyrian Therapeutics, Inc?
Fundz holds 2 contacts at Aspyrian Therapeutics, Inc., including the Vice President Finance Accounting. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Biotechnology around the same time

Companies in the same sectors as Aspyrian Therapeutics, Inc. that raised within 45 days of this round, from Fundz verified event records.

  • Axion BioSystems raised $8M on October 5, 2018.
  • GI DYNAMICS, INC. raised $2.2M (Seed) on October 5, 2018.
  • Kula Bio raised $400K (Seed) on October 5, 2018.
  • Keriton raised $500K (Seed) on October 4, 2018.
  • Spyryx Biosciences, Inc. raised $5.9M on October 4, 2018.
  • Biocartis Group NV raised $138K (Pre-Seed) on October 4, 2018.

Who to call at Aspyrian Therapeutics, Inc., and when

A new round usually means Aspyrian Therapeutics, Inc. is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Aspyrian Therapeutics, Inc. raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Aspyrian Therapeutics, Inc., from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Aspyrian Therapeutics, Inc.. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Aspyrian Therapeutics, Inc.

Location

10581 ROSELLE STREET, SUITE 115

San Mateo, California, United States

About

Aspyrian Therapeutics is developing a first-in-class cancer treatment utilizing photoimmunotherapy.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Aspyrian Therapeutics, Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

2 contacts
Verified contactsShinichi F., Vice President Finance Accounting hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Aspyrian Therapeutics, Inc.'s next move

See what Strategic adds

Aspyrian Therapeutics, Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.